AllerMates(R) Launching EpiPen(R), Auvi-Q(TM) & Asthma Inhaler Carrying … – Wall Street Journal


NBC Latino

AllerMates(R) Launching EpiPen(R), Auvi-Q(TM) & Asthma Inhaler Carrying
Wall Street Journal
"May is the coming of spring, a happy time for most of us, but a challenging time for people, and especially kids, with asthma or allergy-related health ailments," says AllerMates Founder and CEO Iris Shamus. "In response to this important message we
For the Pollen-Affected, Let's Talk AllergiesPatch.com
Pollen count continues to fall for third straight dayAtlanta Journal Constitution
Stop the sneezes: Ways to help your kids deal with seasonal allergiesPennLive.com
NBC Latino –Tallahassee Democrat (blog)
all 14 news articles »

View full post on asthma – Google News

AT&T Demonstrates Asthma Sensor and 4 Hot Stocks Trading Now – Wall St. Cheat Sheet

AT&T Demonstrates Asthma Sensor and 4 Hot Stocks Trading Now
Wall St. Cheat Sheet
CVS Caremark Corporation (NYSE:CVS) sees its retail pharmacy SSS up 0.25 to 1.5 percent, and its pharmacy services segment net revenue growth was at 1.5 to 2.75 percent. The company claims that 2013?s profitability will be affected by various factors,

and more »

View full post on asthma – Google News

Umenyiora’s son hospitalized with asthma – Wall Street Journal


NBCSports.com

Umenyiora's son hospitalized with asthma
Wall Street Journal
Associated Press. EAST RUTHERFORD, N.J. — New York Giants defensive end Osi Umenyiora's son was hospitalized and then released Sunday after an asthma attack. Umenyiora left MetLife Stadium immediately after the 41-27 victory over Cleveland to be
Umenyiora's son out of hospital after asthma attackNFL News
Relief for Umenyiora as son is released from hospitalNBCSports.com

all 32 news articles »

View full post on asthma – Google News

Dirtier Lives May Be Just the Medicine We Need – Wall Street Journal


WBUR

Dirtier Lives May Be Just the Medicine We Need
Wall Street Journal
But there's also a long list of modern illnesses that your great-grandparents barely knew: asthma, eczema, hay fever, food allergies, Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis. The coincidence of the rise in these
Worms And Germs: Their Absence May Explain Ills From Allergies To AsthmaWBUR

all 2 news articles »

View full post on asthma – Google News

Report: 1 in 8 NYC kids have asthma – Wall Street Journal


WFUV News

Report: 1 in 8 NYC kids have asthma
Wall Street Journal
Associated Press. NEW YORK — A new report shows that one in eight New York City children have been diagnosed with asthma. That's worse than the national rate, which is about 1 in 10. The New York City Health Department says poor children are
Disparity Among Neighborhoods Seen in Asthma ReportWFUV News
CDC Report: 1 in 8 New York City Kids Have AsthmaCBS Local

all 35 news articles »

View full post on asthma – Google News

Report: 1 in 8 NYC kids diagnosed with asthma – Wall Street Journal


WFUV News

Report: 1 in 8 NYC kids diagnosed with asthma
Wall Street Journal
Associated Press. NEW YORK — A new report shows that one in eight New York City children has been diagnosed with asthma. That's worse than the national rate, which is about 1 in 10. The New York City Health Department says poor children are
Disparity Among Neighborhoods Seen in Asthma ReportWFUV News
CDC Report: 1 in 8 New York City Kids Have AsthmaCBS Local

all 35 news articles »

View full post on asthma – Google News

Glaxo Tries to Shake Marketing Questions on Advair – Wall Street Journal


Wall Street Journal

Glaxo Tries to Shake Marketing Questions on Advair
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News

Glaxo Tries to Shake Marketing Questions – Wall Street Journal


The Guardian

Glaxo Tries to Shake Marketing Questions
Wall Street Journal
GlaxoSmithKline's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair.
Glaxo Executives Cited in Case Now Lead Sanofi, ActelionBusinessweek
WSJ: Glaxo Tries to Shake Marketing QuestionsNASDAQ
Ex-Glaxo execs in U.S. case now lead other drugmakersBend Bulletin
FiercePharma –NPR (blog)
all 46 news articles »

View full post on asthma – Google News